Metlife, Inc. · NYSE:MET

Metlife — Q2 2023 Earnings Presentation

23 slides from Metlife's earnings presentation, Aug 3, 2023

  1. Slide 1: 2Q23 Supplemental Slides

    1 2Q23 Supplemental Slides John McCallion Chief Financial Officer 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other prior public disclosures. Financial results in this presentation reflect LDTI accounting, pursuant to Financial Account

  2. Slide 2: Table of contents

    Table of contents Topic Page No. Net income (loss) to adjusted earnings 3 Adjusted earnings, ex. total notable items, by segment 4 Variable investment income (VII) 5 Investments 7 Direct expense ratio 9 Cash & capital 10 Appendix 11 2

  3. Slide 3: Net income (loss) to adjusted earnings

    Net income (loss) to adjusted earnings 2Q23 (post-tax) $ in millions $ per share1 Net Income (Loss) $370 $0.48 Less: Intent to Transfer Mark-to-Market Impact2 (699) (0.91) Net Investment Gains (Losses)2 (122) (0.16) Net Derivative Gains (Losses) (788) (1.02) Market Risk Benefit Remeasurement Gains (

  4. Slide 4: Adjusted earnings, ex. total notable items, by segment

    Adjusted earnings, ex. total notable items, by segment % Change Key Drivers1 ($ in millions - except per share data) 2Q23 2Q22 % Change (Constant Rate) Favorable Unfavorable Expense Margins; Group Benefits $372 $406 (8%) Volume Growth Underwriting Margins Investment Margins; Retirement and Income So

  5. Slide 5: 2Q23 VII driven by private equity returns

    2Q23 VII driven by private equity returns1 ($ in millions - pre-tax) $389 $221 $24 $0 ($44) ($53) ($53) 2Q22 3Q22 4Q22 1Q23 2Q23 Private Equity Other 1 Quarterly target VII range of $500 million, based on full year 2023 guidance range of ~ $2.0 billion. 5

  6. Slide 6: VII by segment

    VII by segment ($ in millions - post-tax1) 2Q22 3Q22 4Q22 1Q23 2Q23 Group Benefits $7 $(1) $3 $— $4 Retirement and Income Solutions 75 (35) 5 (3) 29 U.S. 82 (36) 8 (3) 33 Asia 101 (18) 4 (25) 84 Latin America 16 — (3) (2) 4 EMEA — — — — — MetLife Holdings 85 (21) 12 2 41 Corporate & Other 23 33 (1)

  7. Slide 7: Strong recurring income supported by higher interest rates and asset growth

    Strong recurring income supported by higher interest rates and asset growth Net Investment Income1 Roll Off vs. Reinvestment ($ in billions) 7% 6.06% $21.3 6% $5.7 $18.2 5% $17.3 4.49% $1.5 $1.2 4% 3.84% 3% $16.1 $15.6 $16.7 2% $4.5 $5.0 $0.4 $0.2 1% $4.8 $4.1 0% 20 20 21 21 22 22 23 FY20 FY21 FY22

  8. Slide 8: High quality commercial mortgage loan (CML) portfolio

    High quality commercial mortgage loan (CML) portfolio1 • Concentrated in high-quality assets and in larger, primary markets LTV and DSCR Matrix $52.7 Billion • 62% average Loan-to-Value (LTV) Ratio and 2.3x average Debt LTV >1.2x 1.0-1.2x <1.0x Total Service Coverage Ratio (DSCR) <65% 52.3% 3.2% 2.4

  9. Slide 9: 2Q23 direct expense ratio of 12.2%, below 12.6% annual target

    2Q23 direct expense ratio1 of 12.2%, below 12.6% annual target 12.6% Annual 12.5% Target 12.2% 12.0% FY22 1Q23 2Q23 1 Direct expense ratio, excluding total notable items related to direct expenses and pension risk transfers (PRT). 9

  10. Slide 10: Cash & capital

    Cash & capital Holding Company Cash1 Capital ($ in billions) • Share repurchases of $0.7 billion in 2Q23 – ~$300 million shares repurchased in July 2023 $5.2 $5.4 • Expected total U.S. Statutory Adjusted Capital2 of $4.5 $17.4 billion at 6/30/23, down 2% from 3/31/23 $4.2 $4.2 • Reinsurance transact

  11. Slide 11: Appendix

    Appendix Wi MetLife

  12. Slide 12: Cautionary Statement on Forward-Looking Statements

    Cautionary Statement on Forward-Looking Statements The forward-looking statements in this presentation, using words such as “anticipate,” “are confident,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “grow,” “guidance,” “if,” “intend,” “likely,” “long-term,” “may,” “near-term,” “o

  13. Slide 13: Explanatory Note on Non-GAAP and Other Financial Information

    Explanatory Note on Non-GAAP and Other Financial Information Any references in this presentation (except in this Explanatory Note on Non-GAAP Financial Information and Reconciliations) to: Should be read as, respectively: (i) net income (loss); (i) net income (loss) available to MetLife, Inc.’s comm

  14. Slide 14: Explanatory Note on Non-GAAP and Other Financial Information (Continued)

    Explanatory Note on Non-GAAP and Other Financial Information (Continued) Any of these financial measures shown on a constant currency basis reflect the impact of changes in foreign currency exchange rates and are calculated using the average foreign currency exchange rates for the most recent period

  15. Slide 15: Explanatory Note on Non-GAAP and Other Financial Information (Continued)

    Explanatory Note on Non-GAAP and Other Financial Information (Continued) Asymmetrical and non-economic accounting adjustments are made to the line items indicated in calculating adjusted earnings: • Net investment income includes earned income on derivatives and amortization of premium on derivative

  16. Slide 16: Explanatory Note on Non-GAAP and Other Financial Information (Continued)

    Explanatory Note on Non-GAAP and Other Financial Information (Continued) Return on equity and related measures • Total MetLife, Inc.’s common stockholders’ equity, excluding AOCI other than FCTA: Total MetLife, Inc.’s common stockholders’ equity, excluding the net unrealized investment gains (losses

  17. Slide 17: Explanatory Note on Non-GAAP and Other Financial Information (Continued)

    Explanatory Note on Non-GAAP and Other Financial Information (Continued) Statistical sales information: • U.S.: ◦ Group Benefits: calculated using 10% of single premium deposits and 100% of annualized full-year premiums and fees from recurring premium policy sales of all products. ◦ Retirement and I

  18. Slide 18: Reconciliation of Net Income (Loss) to Adjusted Earnings Available to Common Shareholders

    Reconciliation of Net Income (Loss) Available to MetLife, Inc.'s Common Shareholders to Adjusted Earnings Available to Common Shareholders 2Q23 2Q22 Earnings Per Earnings Per Weighted Weighted Average Average Common Common Share Diluted1 Share Diluted1 (In millions, except per share data) Net Income

  19. Slide 19: Reconciliation to Adjusted Earnings, Excluding Total Notable Items

    Reconciliation to Adjusted Earnings Available to Common Shareholders, Excluding Total Notable Items 2Q23 Retirement Group & Income Latin MetLife Corporate U.S.1 Benefits1 Solutions1 Asia America EMEA Holdings1 & Other1 (In millions) Adjusted earnings available to common shareholders $ 789 $ 372 $ 41

  20. Slide 20: Reconciliation of Net Investment Income to Adjusted Net Investment Income

    Reconciliation of Net Investment Income to Adjusted Net Investment Income FY20 FY21 FY22 2Q22 2Q23 (In millions) Net investment income $ 17,117 $ 21,395 $ 15,916 $ 3,583 $ 5,072 Less: Adjustments to net investment income Investment hedge adjustments (815) (895) (976) (232) (263) Unit-linked contract

  21. Slide 21: Reconciliation of Premiums, Fees and Other Revenues to Adjusted

    Reconciliation of Premiums, Fees and Other Revenues to Adjusted Premiums, Fees and Other Revenues FY22 1Q23 2Q23 (In millions) Premiums, fees and other revenues $ 56,365 $ 11,517 $ 13,587 Less: Adjustments to premiums, fees and other revenues: Asymmetrical and non-economic accounting — — — Other adj

  22. Slide 22: Expense Detail and Ratios

    Expense Detail and Ratios (In millions, except ratio data) FY22 1Q23 2Q23 Reconciliation of Capitalization of DAC to Adjusted Capitalization of DAC Capitalization of DAC $ (2,614) $ (718) $ (729) Less: Divested businesses (11) — — Adjusted capitalization of DAC $ (2,603) $ (718) $ (729) Reconciliati

  23. Slide 23: MetLife

    iy’ MetLife

MetLife — Q2 2023 Earnings Presentation on 6ix